Step-wise and punctuated genome evolution drive phenotype changes of tumor cells

Area of Science:

• Genomics
• Cancer Biology
• Cellular Evolution

Background:

• Genome evolution follows distinct phases: step-wise continuous and punctuated.
• Chromosome instability (CIN) is a key factor influencing cellular phenotypes.
• Understanding CIN's role in tumor cell evolution is crucial for cancer research.

Purpose of the Study:

• To investigate the contribution of chromosome instability (CIN) to phenotype changes in tumor cells.
• To characterize clonal chromosome aberrations (CCAs) and non-CCAs (NCCAs) under genotoxic stress.
• To analyze the impact of CHI3L1 gene expression and temozolomide treatment on genome evolution and cell behavior.

Main Methods:

• Conventional cytogenetics and array comparative genomic hybridization (aCGH) for characterizing CCAs/NCCAs and copy number alterations (CNAs).
• Cell viability assays and soft agar assays to assess phenotype changes.
• Genotoxic stresses including plasmid transfection, ectopic gene expression (CHI3L1), and temozolomide treatment.

Main Results:

• Transfection initiated punctuated genome changes in 293 cells, while HeLa cells showed step-wise changes.
• Increased CIN correlated with reduced viability but higher colony formation in 293_pcDNA3.1 cells.
• Temozolomide treatment had opposing effects on genome evolution and cell phenotypes in 293 and HeLa cell lines, highlighting context-dependent responses.

Conclusions:

• Chromosome instability (CIN) significantly influences tumor cell growth characteristics and phenotype.
• The genetic network and genome context dictate the versatile and sometimes opposite effects of genes and treatments.
• Consistent coevolution of karyotypes and phenotypes underscores the importance of considering CIN in experimental manipulations and cancer biology.